Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antimalarial cabamiquine inhibits blood-stage of different field isolates of Plasmodium species.

BMC infectious diseases·2026
Same author

Collateral hypersensitivity between ZY19489 and piperaquine neutralizes PfCRT-mediated drug efflux and Plasmodium falciparum resistance.

Nature communications·2026
Same author

Self-Organized Men's Mental Health and Well-Being Groups-An Emerging Social Development.

American journal of men's health·2026
Same author

Mass drug administration of praziquantel lowers the susceptibility of school-aged children to <i>Schistosoma mansoni</i> in endemic areas.

Frontiers in immunology·2026
Same author

Evidence on the preparedness and practice needs of the home care workforce to support older LGBTQ+ people: a rapid review protocol.

BMJ open·2026
Same author

Collateral hypersensitivity between ZY19489 and piperaquine neutralizes PfCRT-mediated drug efflux and Plasmodium falciparum resistance.

Research square·2025

Related Experiment Video

Updated: May 9, 2026

Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds
07:14

Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds

Published on: July 11, 2025

Antimalarial drug discovery - the path towards eradication.

Jeremy N Burrows1, Emilie Burlot1, Brice Campo1

  • 1Medicines for Malaria Venture, ICC, 20 Route de Pré-Bois - PO Box 1826, 1215 Geneva 15, Switzerland.

Parasitology
|July 19, 2013
PubMed
Summary

Malaria control requires new strategies beyond yearly treatment to reduce transmission and eradicate the parasite. This article reviews current treatments and emerging medicines from Medicines for Malaria Venture (MMV) for next-generation combination therapies.

More Related Videos

Understanding the Development of Compensatory Pathways in a Mutant Malaria Parasite Harbouring Hypomorphic Allele of Plant-Like Kinases
09:13

Understanding the Development of Compensatory Pathways in a Mutant Malaria Parasite Harbouring Hypomorphic Allele of Plant-Like Kinases

Published on: November 22, 2024

Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors
05:28

Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors

Published on: May 12, 2022

Related Experiment Videos

Last Updated: May 9, 2026

Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds
07:14

Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds

Published on: July 11, 2025

Understanding the Development of Compensatory Pathways in a Mutant Malaria Parasite Harbouring Hypomorphic Allele of Plant-Like Kinases
09:13

Understanding the Development of Compensatory Pathways in a Mutant Malaria Parasite Harbouring Hypomorphic Allele of Plant-Like Kinases

Published on: November 22, 2024

Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors
05:28

Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors

Published on: May 12, 2022

Area of Science:

  • Tropical medicine
  • Parasitology
  • Drug discovery

Background:

  • Malaria remains a significant global health burden, necessitating sustainable control strategies.
  • Current disease control methods alone are insufficient for long-term eradication.
  • Reducing parasite transmission is crucial for malaria elimination.

Purpose of the Study:

  • To review current malaria treatments and highlight emerging drug candidates.
  • To explain the discovery process for new antimalarial medicines.
  • To outline strategies for developing next-generation combination therapies for malaria eradication.

Main Methods:

  • Review of existing malaria treatment protocols.
  • Analysis of clinical development pipelines for new antimalarial molecules from Medicines for Malaria Venture (MMV) and partners.
  • Description of drug discovery and research phases for novel compounds.

Main Results:

  • Identification of key advancements in current malaria treatments.
  • Overview of promising new clinical molecules under development by MMV and collaborators.
  • Demonstration of the research journey for novel antimalarial drug candidates.

Conclusions:

  • Sustainable malaria control requires a shift towards parasite eradication.
  • Emerging therapies and combination strategies are essential for future malaria elimination efforts.
  • Continued investment in drug discovery and development is vital for combating malaria.